News

Event
Partner
Milestone
Milestone
2019-07-18

ACT Genomics Wins Taiwan Bio Industry Organization Awards- Emerging Company of the Year

ACT Genomics drives innovation in global standard and individual markets, winning Taiwan Bio Industry Organization Awards- Emerging Company of the Year.

Place:

Taipei

Milestone
2019-07-05

ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park

ACT Genomics Holdings Co., Ltd, a leading cancer precision treatment solution provider, opened its third Next Generation Sequencing (“NGS”) laboratory in Asia at the Hong Kong Science Park, an innovation and technology centre spearheaded by HKSTP.

Place:

Hong Kong

Milestone
2019-04-19

ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

More precision cancer medicine are available for clinical needs and drug development in Japan! Find out more at the new analysis laboratory "Shonan iPark Laboratory" of ACTmed, a joint venture between Canon Medical Systems and ACT Genomics in Japan.

Place:

Japan

Milestone
2019-03-07

New Panel Launched: ACTBRCA HRD

ACTBRCA HRD is a new panel that sequences 48 genes including germline and somatic BRCA1/2, as well as other homologous recombination repair (HRR) genes, to assist physicians in identifying more patients for PARP inhibitors.

Place:

Milestone
2018-12-05

ACTOnco+ received National Innovation Award in Taiwan!

ACTOnco+ won the National Innovation Award in the the Precision Medicine section in Taiwan. ACTOnco+ was awarded for providing actionable solutions to cancer patients around Asia.

Place:

Taiwan

Milestone
2018-11-24

ACT Genomics Completed Another Round of Equity Financing

ACT Genomics is pleased to announce the completion of the latest round of equity financing from a group of international investors co-led by CLSA Capital Partners to support the establishment of new CAP-accredited lab in HK, as well as R&D effort.

Place:

Milestone
2018-11-22

Dr. Allen Lai wins the Executive of the Year – Biotechnology award in Singapore

Dr. Allen Lai, Senior Vice President of ACT Genomics, wins the Executive of the Year – Biotechnology award in Singapore Business Review Management Excellence Awards 2018

Place:

Singapore

Milestone
2018-11-01

Canon Medical partners with ACT Genomics!

Canon Medical System Corporation officially acquired ACT Genomics’ joint venture company in Japan, ACTmed! ACT Genomics will transfer its clinical NGS technology and help operate cancer genomic profiling service in Japan.

Place:

Milestone
2018-07-07

ACT Genomics joins TMB Harmonization Project to standardize calculation of tumor mutational burden

ACTG joins TMB Harmonization Project that aims to create standardization when using different tests to calculate TMB, an important biomarker for predicting immunotherapy response.

Place:

Milestone
2018-05-01

ACT Genomics introduced how genomic profiling services can overcome the challenges in late-stage cancer treatment

The challenges in cancer treatment is not having no cure but how to find appropriate cancer treatment plan among multiple options to avoid side effect and make the cancer treatment more effective .

Place:

Taipei